Background There is considerable international interest in exploiting the potential of digital
solutions to enhance the quality and safety of health care. Implementations of transformative …

On May 19, 2021, the Delta Variant of Concern (VOC), formerly known as the Indian VOC or
B 1.617. 2, became the dominant strain of SARS-CoV-2 in Scotland. The Alpha VOC (…

Objective To develop and validate version two of the QRISK cardiovascular disease risk
algorithm (QRISK2) to provide accurate estimates of cardiovascular risk in patients from different …

Background The BNT162b2 mRNA (Pfizer–BioNTech) and ChAdOx1 nCoV-19 (Oxford–AstraZeneca)
COVID-19 vaccines have shown high efficacy against disease in phase 3 clinical …

Emerging reports of rare neurological complications associated with COVID-19 infection and
vaccinations are leading to regulatory, clinical and public health concerns. We undertook a …

The Global Initiative for Asthma (GINA) Strategy Report provides clinicians with an annually
updated evidence-based strategy for asthma management and prevention, which can be …

Although myocarditis and pericarditis were not observed as adverse events in coronavirus
disease 2019 (COVID-19) vaccine trials, there have been numerous reports of suspected …

Background Allergic rhinitis (AR) affects 10% to 40% of the population. It reduces quality of
life and school and work performance and is a frequent reason for office visits in general …

Methods We searched our own database of papers, conducted a Medline search, and
approached experts for additional published references (further details available from SAM). We …

Objective To develop and validate a pragmatic risk score to predict mortality in patients admitted
to hospital with coronavirus disease 2019 (covid-19). Design Prospective observational …